38 results on '"Jarnagin, W.R."'
Search Results
2. Multidisciplinary, perioperative care bundle decreases surgical site infection in patients undergoing synchronous colorectal/liver resection.
3. Robotic vs open hepatic artery infusion pump placement: a propensity score matching weights analysis.
4. Genomic predictors of response to hepatic artery pump chemotherapy in colorectal liver metastases.
5. Distinct genomic profiles are associated with minimal pathological response to preoperative hepatic artery infusion chemotherapy in initially unresectable colorectal liver metastases.
6. Defining textbook outcomes in surgery of perihilar cholangiocarcinoma: a machine-learning analytics model to select combined - short and long-term - predictors of optimal postoperative course.
7. Survival outcomes and genetic characteristics of resected pancreatic acinar cell carcinoma.
8. Liver transplantation for intrahepatic cholangiocarcinoma: what percentage of patients are eligible?
9. Robotic versus open placement of hepatic artery infusion pumps: a bi-institutional propensity score matching weights analysis.
10. Liver transplantation for intrahepatic cholangiocarcinoma: what percentage of patients are eligible?
11. Risk perceptions and risk thresholds in the management of intraductal papillary mucinous neoplasms.
12. Post-Hawthorne effect: Rise in SSI after bundle implementation in combined liver-colorectal surgery.
13. A Patient-Level Comparison of Systemic Chemotherapy and Hepatic Arterial Infusion Pump Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma.
14. Ten Year Survival after Repeat Local Treatment for Colorectal Liver Metastases: A Multicenter Analysis.
15. Actual 10-Year Survival after Resection of Perihilar Cholangiocarcinoma: What Factors Preclude Cure?
16. Outcomes following transarterial embolization for hepatocellular carcinoma with complete radiologic response.
17. Prediction of Early Extrahepatic Recurrence after Resection of Colorectal Liver Metastases to Guide the Use of Perioperative Systemic and Hepatic Arterial Infusion Chemotherapy.
18. Hepatic Artery Infusion Chemotherapy Combined with Modern Systemic Therapy in Chemotherapy-Naive Patients with Unresectable Colorectal Liver Metastases.
19. Persistent disparities in treatment and survival for patients with pancreatic cancer despite insurance expansion policies.
20. Postoperative liver failure risk score identifying patients with resectable perihilar cholangiocarcinoma who may benefit from portal vein embolization.
21. Postoperative liver failure risk score identifying patients with resectable perihilar cholangiocarcinoma who may benefit from portal vein embolization.
22. Resection or HAIP Chemotherapy for Multifocal Intrahepatic Cholangiocarcinoma.
23. Pathology remains the most important predictor of long-term survival using a modern prognostic nomogram for resected pancreatic ductal adenocarcinoma.
24. Hepatocellular carcinoma in patients with no identifiable risk factors.
25. Longitudinal follow-up of a prospective phase II trial of neoadjuvant gemcitabine and oxaliplatin in patients with resectable pancreas adenocarcinoma reveals distinct patterns of survivorship.
26. Lending a hand for laparoscopic distal pancreatectomy: The optimal approach?
27. Non-alcoholic fatty liver disease is an independent predictor of recurrence after resection of colorectal liver metastases.
28. Histopathological growth patterns and positive margins after resection of colorectal liver metastases.
29. Recurrence rate and patterns with and without perioperative systemic chemotherapy after resection of colorectal liver metastases.
30. Resection of parenchymal liver metastases in patients with uterine malignancies.
31. Invasive central venous monitoring during hepatic resection: unnecessary for most cases.
32. Interrogation of XPO7 pathobiology in cholangiocarcinoma to elucidate therapeutic vulnerabilities.
33. Recurrence rate and pattern after resection of colorectal liver metastases with and without hepatic arterial infusion chemotherapy.
34. Patterns of recurrence and peri-operative predictors of liver metastasis after pancreatic cancer resection.
35. Outcomes after pancreatectomy with routine usage of pasireotide.
36. Change in circulating tumor DNA after hepatic resection for metastatic colorectal cancer.
37. Regional differences in gallbladder cancer pathogenesis: Insights from a comparison of tumor mutations.
38. Behind the cyst: predicting grade of dysplasia in intraductal papillary mucinous neoplasms (IPMNs) by quantitative image analysis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.